These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16852343)

  • 21. Interpreting the aggregation kinetics of amyloid peptides.
    Pellarin R; Caflisch A
    J Mol Biol; 2006 Jul; 360(4):882-92. PubMed ID: 16797587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FTIR spectroscopic studies on aggregation process of the beta-amyloid 11-28 fragment and its variants.
    Juszczyk P; Kołodziejczyk AS; Grzonka Z
    J Pept Sci; 2009 Jan; 15(1):23-9. PubMed ID: 19023881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight.
    Davis TJ; Soto-Ortega DD; Kotarek JA; Gonzalez-Velasquez FJ; Sivakumar K; Wu L; Wang Q; Moss MA
    Mol Pharmacol; 2009 Aug; 76(2):405-13. PubMed ID: 19483107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular insight into the inhibition effect of trehalose on the nucleation and elongation of amyloid beta-peptide oligomers.
    Liu FF; Ji L; Dong XY; Sun Y
    J Phys Chem B; 2009 Aug; 113(32):11320-9. PubMed ID: 19719268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring interaction of beta-amyloid segment (25-35) with membrane models through paramagnetic probes.
    Esposito C; Tedeschi A; Scrima M; D'errico G; Ottaviani MF; Rovero P; D'ursi AM
    J Pept Sci; 2006 Dec; 12(12):766-74. PubMed ID: 17131288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Abeta fibrils and protofibrils.
    Arimon M; Grimminger V; Sanz F; Lashuel HA
    J Mol Biol; 2008 Dec; 384(5):1157-73. PubMed ID: 18851977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model of Alzheimer's disease amyloid-beta peptide based on a RNA binding protein.
    Mathura VS; Paris D; Ait-Ghezala G; Quadros A; Patel NS; Kolippakkam DN; Volmar CH; Mullan MJ
    Biochem Biophys Res Commun; 2005 Jul; 332(2):585-92. PubMed ID: 15896718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
    Benseny-Cases N; Cócera M; Cladera J
    Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of different salt ions on the propensity of aggregation and on the structure of Alzheimer's abeta(1-40) amyloid fibrils.
    Klement K; Wieligmann K; Meinhardt J; Hortschansky P; Richter W; Fändrich M
    J Mol Biol; 2007 Nov; 373(5):1321-33. PubMed ID: 17905305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probing the kinetics of beta-amyloid self-association.
    Murphy RM; Pallitto MM
    J Struct Biol; 2000 Jun; 130(2-3):109-22. PubMed ID: 10940219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Branched KLVFF tetramers strongly potentiate inhibition of beta-amyloid aggregation.
    Chafekar SM; Malda H; Merkx M; Meijer EW; Viertl D; Lashuel HA; Baas F; Scheper W
    Chembiochem; 2007 Oct; 8(15):1857-64. PubMed ID: 17763487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
    Sakono M; Zako T; Ueda H; Yohda M; Maeda M
    FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids.
    Sciarretta KL; Boire A; Gordon DJ; Meredith SC
    Biochemistry; 2006 Aug; 45(31):9485-95. PubMed ID: 16878983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloidogenic properties of the prion protein fragment PrP(185-208): comparison with Alzheimer's peptide Abeta(1-28), influence of heparin and cell toxicity.
    Cortijo-Arellano M; Ponce J; Durany N; Cladera J
    Biochem Biophys Res Commun; 2008 Apr; 368(2):238-42. PubMed ID: 18206983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling of the Zn2+ binding in the 1-16 region of the amyloid beta peptide involved in Alzheimer's disease.
    Furlan S; La Penna G
    Phys Chem Chem Phys; 2009 Aug; 11(30):6468-81. PubMed ID: 19809679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A beta fibrillogenesis: kinetic parameters for fibril formation from congo red binding.
    Inouye H; Kirschner DA
    J Struct Biol; 2000 Jun; 130(2-3):123-9. PubMed ID: 10940220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuated cytotoxicity but enhanced betafibril of a mutant amyloid beta-peptide with a methionine to cysteine substitution.
    Dai XL; Sun YX; Jiang ZF
    FEBS Lett; 2007 Apr; 581(7):1269-74. PubMed ID: 17349630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the mechanism of beta-amyloid fibril formation by kinetic and thermodynamic analyses.
    Lin MS; Chen LY; Tsai HT; Wang SS; Chang Y; Higuchi A; Chen WY
    Langmuir; 2008 Jun; 24(11):5802-8. PubMed ID: 18452319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition.
    Li Q; Gordon M; Etienne MA; Hammer RP; Morgan D
    Cell Transplant; 2008; 17(4):397-408. PubMed ID: 18522242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of fibrillogenesis of amyloid beta(1-40) peptide with cationic gemini surfactant.
    Cao M; Han Y; Wang J; Wang Y
    J Phys Chem B; 2007 Nov; 111(47):13436-43. PubMed ID: 17983218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.